ARCH Research Protocol for Provider Alcohol Pharmacotherapy Training and Assessment

HIV Clinical Trial

— ARCH  

Official title:

Integration of Evidence-based Alcohol Interventions Into HIV Care (ARCH-IRA) (Phases 1- Provider Training and 2- Patient Intervention)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02610517
• Other study ID #: F121009007
• Status: Completed
• Phase: N/A
• Start date: June 2013
• Est. completion date: February 2016

Study information

• Verified date: May 2024
• Source: University of Alabama at Birmingham
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Phase 1: To train providers to offer alcohol pharmacotherapy to at-risk drinkers interested in quitting or reducing their drinking as part of overall HIV care. Phase 2: To determine the effectiveness of a computer-delivered brief intervention (CBI) for reducing hazardous drinking in the HIV clinical care setting.

Description:

This study is divided into 2 phases: provider training (Phase 1) and patient level intervention (Phase 2). Phase 1, provider training, is managed through an administrative grant at Johns Hopkins. Providers will be notified of the research project locally but all training and assessments will be through Johns Hopkins.

Phase 1:

Training providers to offer alcohol pharmacotherapy (APT) to at-risk drinkers interested in quitting or reducing their drinking as part of overall HIV care could be an important strategy to reduce hazardous alcohol use in this medically-ill population. However, it is unknown how Infectious Disease providers will feel about treating alcohol use disorders within HIV clinics. Further it is uncertain the specific provider and clinic barriers to implementing this type of program in a primary care setting. A web-based alcohol pharmacotherapy provider training will be provided across the Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS), a national network of 8 clinical cohorts. At the two intervention sites (University of Alabama at Birmingham and the University of Washington), providers will receive an on-site training in addition to the web-based training on alcohol pharmacotherapy administered at all 8 sites.

The following are the specific aims of this project:

Aim 1: To evaluate provider attitudes before and after alcohol pharmacotherapy training.

Aim 2: To determine barriers and facilitators to alcohol treatment implementation in HIV specialty clinics.

Phase 2:

Determine the effectiveness of computer-delivered brief interventions (CBI) for reducing hazardous drinking in the HIV clinical care setting at two intervention clinics: University of Alabama at Birmingham (UAB) and the University of Washington (UW). The combination of CBI plus alcohol pharmacotherapy (APT) provider training (Phase 1) will be piloted in two clinics in the Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS), a national network of 8 clinical cohorts. Across all 8 CNICS sites, all patients will be screened for hazardous or binge drinking using the AUDIT (Alcohol Use Disorders Identification Test) and MINI (Mini-International Neuropsychiatric Interview) instruments. At UAB and UW, patients who screen eligible (self-report of hazardous or binge drinking using the AUDIT and MINI instruments) will be approached for participation. The data collected through this protocol will be used to compare Standard of Care as noted in Aim 2 below. Standard of Care at UAB includes potential referral to an in-house substance abuse program or an outside agency, both of which are based on the provider's discretion. Providers have the option of offering alcohol pharmacotherapy but this has not been used to date routinely.

Specific aims of this proposal are:

Aim 1: Develop a tailored CBI intervention that addresses alcohol risks specific to HIV-infected patients.

Aim 2: Compare the effectiveness of CBI + APT versus standard care for reducing alcohol use among hazardous drinking HIV infected individuals.

Aim 3: Determine patient-level predictors of CBI and APT engagement and effectiveness.

Aim 4: Determine the facilitators and barriers to successful integration and implementation of these interventions into HIV clinical settings.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 117
• Est. completion date: February 2016
• Est. primary completion date: February 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• At least 18 years or older

• Receiving HIV care at The UAB 1917 Clinic

• Hazardous drinkers as defined by an at-risk alcohol use score on the alcohol related, self-report data collected through the CNICS PRO.

• English speaking

• Willing to participate and provide informed consent

Exclusion Criteria:

• Pregnant or nursing women will be referred to social work for more intensive intervention per standard of care.

• Cognitive impairment such as they cannot provide informed consent

• Non-English speaker

• A visibly intoxicated person will be deferred for consent by the research assistant but will remain eligible for the study

• Patients who previously declined to participate in the project

Related Conditions & MeSH terms

• Alcoholism
• HIV

Intervention

Behavioral:
• Provider Training
All providers will receive an online survey about alcohol pharmacotherapy, and an on-site training on alcohol pharmacotherapy will be offered at UAB and UW. The training will cover the most commonly prescribed alcohol pharmacotherapy. Some medications (ex: Zofran) have been used clinically for alcohol pharmacotherapy but have not yet received FDA approval for this indication. Research has shown these medications are beneficial as alcohol pharmacotherapy and are more frequently used by doctors due to the more favorable side effects. Providers in this study will use their clinical judgment in prescribing alcohol medications per their normal standard of care and using any new information gained from the alcohol pharmacotherapy training.
• Patient Intervention
Eligible participants will be screened using the Audit and Mini instruments that are routinely asked during regular clinic visits. Once a participant consents, they will be shown 2 computerized brief interventions (CBIs) - one after enrollment (visit 1) and one 3-6 months after enrollment (visit 2). Participants will interact with the touch-screen computer via Peedy the Parrot, a three dimensional animated character. The intervention emphasizes personal responsibility for change, uses empathy as a counseling style, and enhances self-efficacy. At the end of both visits, patients will complete a patient satisfaction survey with questions related to ease of use of CBI and satisfaction with program content. Providers will have the opportunity to prescribe pharmacotherapy at visit 1 and 2.

Locations

Country	Name	City	State
United States	Johns Hopkins University	Baltimore	Maryland
United States	University of Alabama at Birmingham	Birmingham	Alabama
United States	University of Washington	Seattle	Washington

Sponsors (3)

Lead Sponsor	Collaborator
University of Alabama at Birmingham	Johns Hopkins University, University of Washington

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Drinks per week	The Alcohol Use Disorders Identification Test (AUDIT) instrument will be used to assess drinks per week. This is a self-reported instrument.	up to 1 year after enrollment
Primary	Binge drinking episodes	The Mini-International Neuropsychiatric Interview (MINI) instrument will be used to assess binge drinking episodes. This is a self-reported instrument.	up to 1 year after enrollment
Secondary	Number of participants that initiate/request alcohol pharmacotherapy	Prescription of alcohol pharmacotherapy - number of participants obtaining a prescription at enrollment and/or after visit 2.	at enrollment and after visit 2 (3 - 6 months after enrollment)
Secondary	Number of participants that complete a CNICS Patient Reported Outcome (PRO)	The CNICS PRO is a patient self-reported questionnaire that is asked every 3 - 6 months during a regular clinic visit. The instruments that are used include: Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST); Adult AIDS Clinical Trials Group (AACTG) Adherence; HIV Risk Behaviors; Quality of Life (EuroQOL); Patient Health Questionnaire for Depression and Anxiety (PHQ-9 - Depression; PHQ-5 - Anxiety); Tobacco; Physical Activity	every 3 - 6 months after enrollment and at 12 months after enrollment
Secondary	Number of participants that initiate antiretroviral therapy (ART)	New prescription of ART if they previously were not on therapy	every 3 - 6 months after enrollment and at 12 months after enrollment
Secondary	Mean number of participants that adhere to HIV clinic visits	Medical records data will be used to record the data	for 1 year after enrollment
Secondary	Number of subjects with HIV-RNA level (viral loads) < 20 copies/ml	Virological suppression to < 20 copies/ml	1 year post enrollment